A Sugar Land cell bank and cGMP manufacturer whose therapy reaches patients only through FDA authorized trials
Hope Biosciences is a biopharmaceutical company and cell bank at 16700 Creek Bend Drive in Sugar Land, about twenty miles southwest of Houston. Donna Chang founded it in 2016. The company bought the building it occupies and won a $1 million performance incentive from the City of Sugar Land in January 2026. Inside are ISO 7 and ISO 8 cleanrooms run to cGMP standards under an ISO 9001:2015 quality system, and the company says it is the only clinical grade bank in the United States storing mesenchymal stem cells from both adults and newborns. What a member of the public can actually buy here is banking. About a tablespoon of fat from an adult, or the placenta and amniotic membrane after a birth, goes through a five to seven week culture process that builds a master cell bank the company expects to yield more than a thousand doses. Prices are published and identical for adults and newborns. One payment of $10,000 settles it, or you can pay $7,000 with $250 a year after that, or $3,950 with $500 a year. Samples are collected in the Greater Houston area and shipped in by kit from anywhere else in the country. Treatment is a separate matter and it is not for sale. Because the cultured cells are regulated as drug products, Hope Biosciences can release them only inside an FDA authorized study, and those run through the Hope Biosciences Research Foundation, a 501(c)(3) founded in 2020 at the same address that charges patients nothing. Protocols have covered multiple sclerosis, Parkinson's disease, rheumatoid arthritis, lupus, post COVID syndrome, brain injury and Crohn's disease. The multiple sclerosis work is furthest along. A 24 patient Phase 2 of autologous HB-adMSCs met its primary endpoint in 2024, and in August 2025 the FDA granted the cells RMAT designation for relapsing remitting MS. All of it remains investigational and none of it is FDA approved.
GMP-Certified Lab
Good Manufacturing Practice
ISO 9001
International Organization for Standardization
Research / Clinical-Trial Participation
Accreditations are records-based and do not imply endorsement of any treatment's safety or efficacy.
Starting from
$3,950
package
Typical range
$3,950 to $10,000
Banking is the only thing with a published price. One programme, three payment plans, the same for adults and newborns. $10,000 once, or $7,000 plus $250 a year, or $3,950 plus $500 a year. Treatment is not sold. Cells are released only into FDA authorized studies run by the nonprofit Hope Biosciences Research Foundation, which states those studies cost patients nothing.
Pricing is indicative and set by each clinic. Confirm the final cost directly before treatment.
Individual results vary and are not typical or guaranteed. Case studies and testimonials reflect one person's experience.
No patient reviews have been published for Hope Biosciences in Sugar Land, United States yet. If you were treated here, your account is the one that helps the next patient.
Third-party sources, summarised by our editors and quoted where a reviewer said it best. These are not Hope Biosciences's reviews on this site and are not counted in its rating here.
4.8out of 5 on Google from 17 ratings
A short listing, and almost every review is about the banking service rather than treatment, which matches what the company actually sells to the public. Reviewers describe the fat collection appointment as quick and well organised, and several frame the decision as insurance against a future diagnosis. Staff are named warmly.
Most-mentioned on Google
Checked . Figures on the source may have changed since. View the Google listing
The most discussed clinic of this group. In r/covidlonghaulers a participant in the company's long COVID trial documented each infusion at length and posted readings showing improved oxygen saturation and blood pressure, while saying plainly they were not back to normal. Commenters mostly asked how to enrol. r/stemcells carries the traumatic brain injury results and a meeting with federal health officials. Tone is hopeful and closely followed rather than sceptical.
Recurring points
Checked . Figures on the source may have changed since.
Donna Chang
Co-Founder, President and Chief Executive Officer
Graduate degree in biotechnology, Johns Hopkins University
Started Hope Biosciences in Sugar Land in 2016 with one employee, after studying premed at the University of Toronto and working in economic development recruiting life sciences companies to Texas. She co-founded the nonprofit Hope Biosciences Research Foundation in 2020 and speaks for the company on its FDA filings.
Hyeonggeun Park
Lab Director
Named by the company as the inventor of its cell culture technology, the five to seven week process that turns a small fat or placenta sample into a master cell bank. He runs the Sugar Land laboratory.
Dr. Djamchid Lotfi
Principal Investigator, Hope Biosciences Research Foundation
MD
Listed on clinicaltrials.gov as principal investigator for the foundation's Phase 2 study of autologous HB-adMSCs in multiple sclerosis (NCT06800404), running at Sugar Land since May 2025.
Ridhima Vij
Clinical Research Scientist
Works on the HB-adMSC programme and reported the Phase 2 multiple sclerosis findings in the company's August 2025 announcement of its RMAT designation.
Not yet verified
This clinic has not completed verification. Listings are still curated, but accreditation hasn't been confirmed.
Share a few details and Hope Biosciences will reach out by email. Your information is never shown publicly.
40% Regenerative Orthopedics ยท 30% Bone-Marrow-Derived Therapy ยท 20% Platelet-Rich Plasma (PRP)
Pricing on consultation
45% Regenerative Orthopedics ยท 25% Bone-Marrow-Derived Therapy ยท 20% Platelet-Rich Plasma (PRP)
Starting from
โฉ250,000
30% IV / Systemic Cell Therapy ยท 25% Mesenchymal Stem Cell (MSC) Therapy ยท 15% Adipose-Derived Stem Cell Therapy
Starting from
$5,000